SEARCH

SEARCH BY CITATION

References

  • 1
    Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005; 150: 11151121.
  • 2
    Casey DE. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am. J. Med. 2005; 118 (Suppl. 2): 15S22S.
  • 3
    Gurpegui M, Martínez-Ortega JM, Gutiérrez-Rojas L, Rivero J, Rojas C, Jurado D. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012; 37: 169175.
  • 4
    Organization for Economic Co-operation and Development. OECD health data, 2011. [Cited 25 October 2012.] Available from URL: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT (last accessed 24 July 2013).
  • 5
    Kitabayashi Y, Narumoto J, Kitabayashi M, Fukui K. Body mass index among Japanese inpatients with schizophrenia. Int. J. Psychiatry Med. 2006; 3: 93102.
  • 6
    Berrington de Gonzalez A, Hartge P, Cerhan JR et al. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 2010; 363: 22112219.
  • 7
    Zheng W, McLerran DF, Rolland B et al. Association between body-mass index and risk of death in more than 1 million Asians. N. Engl. J. Med. 2011; 364: 719729.
  • 8
    Ministry of Health, Labour and Welfare. 2009. Patient survey. [Cited 25 October 2012.] Available from URL: http://www.ncnp.go.jp/nimh/keikaku/vision/630data.html (last accessed 24 July 2013).
  • 9
    Okamura T, Tanaka H, Miyamatsu N et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007; 190: 216223.
  • 10
    Ministry of Health, Labour and Welfare. 2010. National health and nutrition examination survey. [Cited 25 October 2012.] Available from URL: http://www.mhlw.go.jp/bunya/kenkou/eiyou/h22-houkoku.html (last accessed 24 July 2013).
  • 11
    Crews MP, Howes OD. Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications. Hum. Psychopharmacol. 2012; 27: 1523.
  • 12
    Burge RT. The cost of osteoporotic fractures in the UK: Projections for 2000–2020. J. Med. Econ. 2001; 4: 5162.
  • 13
    Sugawara N, Yasui-Furukori N, Sato Y et al. Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. Ann. Gen. Psychiatry 2011; 10: 2128.